Skip to main content
Premium Trial:

Request an Annual Quote

USDA Buys Waters Acquity System

NEW YORK (GenomeWeb News) – The US Food and Drug Administration has purchased a Waters Acquity TQD mass spectrometry system to develop methods for screening poultry and beef for veterinary drugs, Waters said today.

The Acquity TQD system will be used in the USDA's Agricultural Research Service's Wyndmoor, Pa., research lab.

The USDA plans to use the testing methods to find drugs that are used in poultry and livestock to protect from disease and to promote growth, but which, through "ignorance, carelessness, or deceit on the part of a small number of producers" can enter the food chain. Some of these drugs are either banned substances or are illegal at certain concentration levels, Waters noted.

The Waters mass spec system utilizes the company's MassLynx 4.1 software.

Financial terms of the agreement were not released.

The Scan

Positive Framing of Genetic Studies Can Spark Mistrust Among Underrepresented Groups

Researchers in Human Genetics and Genomics Advances report that how researchers describe genomic studies may alienate potential participants.

Small Study of Gene Editing to Treat Sickle Cell Disease

In a Novartis-sponsored study in the New England Journal of Medicine, researchers found that a CRISPR-Cas9-based treatment targeting promoters of genes encoding fetal hemoglobin could reduce disease symptoms.

Gut Microbiome Changes Appear in Infants Before They Develop Eczema, Study Finds

Researchers report in mSystems that infants experienced an enrichment in Clostridium sensu stricto 1 and Finegoldia and a depletion of Bacteroides before developing eczema.

Acute Myeloid Leukemia Treatment Specificity Enhanced With Stem Cell Editing

A study in Nature suggests epitope editing in donor stem cells prior to bone marrow transplants can stave off toxicity when targeting acute myeloid leukemia with immunotherapy.